Cabio Biotech Wuhan Co Ltd (688089) - Total Liabilities

Latest as of September 2025: CN¥183.42 Million CNY ≈ $26.84 Million USD

Based on the latest financial reports, Cabio Biotech Wuhan Co Ltd (688089) has total liabilities worth CN¥183.42 Million CNY (≈ $26.84 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Cabio Biotech Wuhan Co Ltd equity growth rate to track the company's year-over-year net asset growth rate.

Cabio Biotech Wuhan Co Ltd - Total Liabilities Trend (2013–2024)

This chart illustrates how Cabio Biotech Wuhan Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See how much free cash does Cabio Biotech Wuhan Co Ltd generate to measure how efficiently the company converts operating cash flow to free cash.

Cabio Biotech Wuhan Co Ltd Competitors by Total Liabilities

The table below lists competitors of Cabio Biotech Wuhan Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
DUG Technology Ltd AU:DUG	Australia	AU$44.17 Million
Boab Metals Ltd AU:BML	Australia	AU$22.01 Million
LongDa Construction & Development Corp TW:5519	Taiwan	NT$8.56 Billion
JVM Co. Ltd KQ:054950	Korea	₩92.00 Billion
Virgin Galactic Holdings Inc NYSE:SPCE	USA	$627.65 Million
Asian Energy Services Limited NSE:ASIANENE	India	Rs2.97 Billion
Korea Asset In Trust Co Ltd KO:123890	Korea	₩654.89 Billion
ONWARD MEDICAL BV EO -12 F:63E	Germany	€29.24 Million

Liability Composition Analysis (2013–2024)

This chart breaks down Cabio Biotech Wuhan Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Cabio Biotech Wuhan Co Ltd.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	5.79	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.11	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.10	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Cabio Biotech Wuhan Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Cabio Biotech Wuhan Co Ltd (2013–2024)

The table below shows the annual total liabilities of Cabio Biotech Wuhan Co Ltd from 2013 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥117.27 Million ≈ $17.16 Million	-0.28%
2023-12-31	CN¥117.60 Million ≈ $17.21 Million	-36.69%
2022-12-31	CN¥185.77 Million ≈ $27.18 Million	+178.61%
2021-12-31	CN¥66.68 Million ≈ $9.76 Million	+12.44%
2020-12-31	CN¥59.30 Million ≈ $8.68 Million	+22.89%
2019-12-31	CN¥48.26 Million ≈ $7.06 Million	-12.25%
2018-12-31	CN¥54.99 Million ≈ $8.05 Million	+31.01%
2017-12-31	CN¥41.98 Million ≈ $6.14 Million	-43.41%
2016-12-31	CN¥74.17 Million ≈ $10.85 Million	-13.35%
2015-12-31	CN¥85.60 Million ≈ $12.53 Million	+106.19%
2014-12-31	CN¥41.52 Million ≈ $6.08 Million	+4.62%
2013-12-31	CN¥39.68 Million ≈ $5.81 Million	--

About Cabio Biotech Wuhan Co Ltd

SHG:688089 China Biotechnology

Market Cap

$191.61 Million

CN¥1.31 Billion CNY

Market Cap Rank

#16715 Global

#4643 in China

Share Price

CN¥7.78

Change (1 day)

+2.23%

52-Week Range

CN¥6.98 - CN¥29.99

All Time High

CN¥48.06